Intuitive Surgical Inc. (ISRG) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Intuitive Surgical’s revenue went from $2.7B in fiscal 2016 to $10.1B in fiscal 2025, growth of about 15.7% a year.
Net income in fiscal 2025 was $2.9B, a net margin of 28.4%; the highest of the period.
Over the twelve months to September 30, 2026, revenue was $11.6B and net income $3.0B.
Free cash flow was $2.5B in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count rose 3% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.6B | $10.1B | $8.4B | $7.1B | $6.2B | $5.7B | $4.4B | $4.5B | $3.7B | $3.1B | $2.7B |
| Gross profit | $7.8B | $6.6B | $5.6B | $4.7B | $4.2B | $4.0B | $2.9B | $3.1B | $2.6B | $2.2B | $1.9B |
| Operating income | $3.3B | $2.9B | $2.3B | $1.8B | $1.6B | $1.8B | $1.0B | $1.4B | $1.2B | $1.1B | $950M |
| Net income | $3.0B | $2.9B | $2.3B | $1.8B | $1.3B | $1.7B | $1.1B | $1.4B | $1.1B | $671M | $738M |
| EPS (diluted) | $8.26 | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 | $2.94 | $3.85 | $3.16 | $1.92 | $2.09 |
| R&D | $1.5B | $1.3B | $1.1B | $999M | $879M | $671M | $595M | $557M | $418M | $329M | $240M |
| Revenue growth | — | +20.5% | +17.2% | +14.5% | +9.0% | +31.0% | −2.7% | +20.2% | +18.7% | +16.0% | +13.5% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $4.1B | $3.0B | $2.4B | $1.8B | $1.5B | $2.1B | $1.5B | $1.6B | $1.2B | $1.1B | $1.1B |
| Capital spending | -$492M | -$540M | -$1.1B | -$1.1B | -$532M | -$340M | -$342M | -$426M | -$187M | -$191M | -$54M |
| Free cash flow | $3.6B | $2.5B | $1.3B | $750M | $958M | $1.7B | $1.1B | $1.2B | $982M | $953M | $1.0B |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | $4.6B | $2.3B | $0 | $416M | $2.6B | $0 | $134M | $270M | $0 | $2.3B | $42M |
| Stock-based pay | $835M | $788M | $677M | $593M | $513M | $449M | $395M | $336M | $261M | $209M | $178M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $5.9B | $4.0B | $5.2B | $4.1B | $4.2B | $5.1B | $3.2B | $3.1B | $2.0B | $2.6B |
| Debt | — | $171M | $146M | $90M | $94M | $87M | $80M | $76M | $0 | $0 | $0 |
| Equity | — | $17.8B | $16.4B | $13.3B | $11.0B | $11.9B | $9.7B | $8.3B | $6.7B | $4.8B | $5.8B |
| Total assets | — | $20.5B | $18.7B | $15.4B | $13.0B | $13.6B | $11.2B | $9.7B | $7.8B | $5.8B | $6.5B |
| Shares (diluted) | 352M | 363M | 362M | 357M | 362M | 366M | 361M | 358M | 356M | 349M | 354M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 67.2% | 66.0% | 67.5% | 66.4% | 67.4% | 69.3% | 65.6% | 69.5% | 69.9% | 70.2% | 69.9% |
| Operating margin | 28.4% | 29.3% | 28.1% | 24.8% | 25.4% | 31.9% | 24.1% | 30.7% | 32.2% | 33.9% | 35.1% |
| Net margin | 25.5% | 28.4% | 27.8% | 25.2% | 21.2% | 29.8% | 24.3% | 30.8% | 30.3% | 21.4% | 27.3% |
| FCF margin | 31.1% | 24.8% | 15.6% | 10.5% | 15.4% | 30.6% | 26.2% | 26.2% | 26.4% | 30.4% | 38.2% |
| ROIC | — | 14.2% | 12.4% | 12.2% | 11.8% | 13.9% | 9.5% | 15.2% | 15.8% | 13.5% | 12.3% |
| ROE | — | 16.0% | 14.1% | 13.5% | 12.0% | 14.3% | 10.9% | 16.7% | 16.9% | 14.0% | 12.8% |
Frequently asked questions
What is Intuitive Surgical’s annual revenue?
$10.1B in fiscal 2025 and $11.6B over the twelve months to September 30, 2026.
How much profit does Intuitive Surgical make?
Net income was $2.9B in fiscal 2025 (net margin 28.4%).
Is Intuitive Surgical’s revenue growing?
Yes: revenue rose 20.5% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.